Comparative Efficacy of Ceritinib and Crizotinib as Initial Alk-Targeted Therapies in Previously Treated Advanced Nsclc: An Adjusted Comparison with External Controls
AuthID
P-00K-WDV
P-00K-WDV
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service